Welcome to our dedicated page for Trulieve Cannabis news (Ticker: TRLV), a resource for investors and traders seeking the latest updates and insights on Trulieve Cannabis stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Trulieve Cannabis's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Trulieve Cannabis's position in the market.
Trulieve Cannabis (NYSE: TRLV) announced the opening of a new medical cannabis dispensary in Marco Island, Florida, with a grand opening celebration on Friday, July 24. The location at 615 E Elkcam Circle will serve Collier County patients with walk-in and express pickup options.
The dispensary will operate 9 a.m.–8:45 p.m. Monday–Saturday and 10 a.m.–8 p.m. Sundays, offering Trulieve’s in-house brands such as Co2lors, Cultivar Collection, Modern Flower, Momenta, Roll One, and Sweet Talk, plus exclusive Florida partner brands like Alien Labs, Connected Cannabis, Khalifa Kush, Seed Junky, and others. According to Trulieve, Florida patients also have access to home delivery, online ordering, in-store pickup, a 20% veteran discount with military ID, and a 60% new customer discount for first-time guests at any Florida location.
Trulieve Cannabis Corp (NYSE: TRLV) will hold a conference call on Friday, August 7, 2026 at 8:30 AM Eastern Time to discuss its second quarter 2026 financial and operating results. Chairman, Founder and CEO Kim Rivers and CFO Jan Reese will host the call, which will be accessible by phone and live audio webcast, with an archived replay available online.
Trulieve (NYSE: TRLV) announced it has been named to TIME's America's Best Companies 2026 list, which recognizes the top 1,000 U.S. companies. The ranking, compiled by TIME and Statista, evaluates firms on employee satisfaction, financial performance, and sustainability transparency.
More than 7,200 companies met eligibility criteria, and Trulieve is one of only two cannabis companies included. The assessment used about 217,000 employee surveys, multi-year financial data for companies with at least $100 million in revenue, and analysis of environmental, social, and governance disclosures.
Trulieve (NYSE: TRLV) marked Georgia’s expanded medical cannabis program with a ceremonial first sale at its Marietta dispensary. New law SB 220 allows flower and vaporization products for patients 21+ and broadens qualifying conditions. Trulieve is also supplying products to over a dozen licensed independent pharmacies statewide.
Trulieve (NYSE: TRLV) announced that CEO and Chair Kim Rivers plans to terminate her automatic securities disposition plan (ASDP) in the next open trading window on August 11, 2026.
The Rule 10b5‑1 plan covered 2.5 million shares; 1,699,007 have already been sold in the first tranche.
Trulieve (NYSE: TRLV) received approval to list its subordinate voting shares on the New York Stock Exchange, with trading expected to begin June 10, 2026 under ticker TRLV.
The company reports 206 state-licensed medical marijuana dispensaries and 3.5 million square feet of DEA-registered production capacity after a recent restructuring.